Scientific Industries chairman buys 20,000 shares at $0.6048

Scientific Industries Inc (SCND) reported that chairman and director John Moore acquired 20,000 shares of common stock on 12/05/2025 at $0.6048 per share.

Accepted by SEC EDGAR 12/15/2025 - 04:36 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Scientific Industries Inc (SCND) reported that chairman and director John Moore acquired 20,000 shares of common stock on 12/05/2025 at $0.6048 per share. Following this purchase, he directly owns 645,171 shares, giving him a larger personal stake in the company.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 1 txn

Insider MOORE JOHN A

Role Chairman

Bought 20,000 shs ($12K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	20,000	$0.6048	$12K

Holdings After Transaction: Common Stock — 645,171 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Scientific Industries Inc (SCND) report for John Moore?

John Moore acquired 20,000 shares of Scientific Industries Inc common stock at a price of $0.6048 per share.

What is John Moore's role at Scientific Industries Inc (SCND)?

John Moore is listed as a director and officer of Scientific Industries Inc, with the officer title given as Chairman.

How many Scientific Industries Inc (SCND) shares does John Moore own after the transaction?

After the reported purchase, John Moore beneficially owns 645,171 shares of Scientific Industries Inc common stock in direct ownership.

When did John Moore buy the Scientific Industries Inc (SCND) shares and at what price?

The transaction date is 12/05/2025, and John Moore acquired the shares at a price of $0.6048 per share.

Was John Moore's report for Scientific Industries Inc (SCND) filed individually or jointly?

The report indicates that the form was filed by one reporting person, not by more than one reporting person.

Did the reported transaction involve derivative securities of Scientific Industries Inc (SCND)?

The information provided shows activity only in non-derivative common stock; no derivative securities entries appear in the derivative securities table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORE JOHN A

(Last) (First) (Middle)

403 MARSH LANE

(Street)

WILMINGTON DE 19807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ scnd ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/05/2025	12/05/2025	P		20,000	A	$0.6048	645,171	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	John Moore	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.